Solid Biosciences Inc. SLDB Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Solid Biosciences Inc.’s reported figures.
Based on trailing twelve months.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s return on equity?
- Solid Biosciences Inc. (SLDB) reported return on equity of -57.4% in Q1 2026.
- How has Solid Biosciences Inc.'s return on equity changed year-over-year?
- Solid Biosciences Inc.'s return on equity decreased by 3.7% year-over-year, from -55.3% to -57.4%.
- What is the long-term trend for Solid Biosciences Inc.'s return on equity?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s return on equity has grown at a 5.7% compound annual growth rate (CAGR), from -83.2% to -109.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.